I note that yesterday J&J got a conditional approval on their tuberculoisis (TB) drug Bedaquiline. You may remember that this drug was approved by the FDA in late 2012 and represents a new treatment for multidrug resistant TB. One wonders why the EU took over a year longer, was their more concern with some of …